文献速递神经核医学

多系统萎缩帕金森型脑干5-羟色胺转运体分布:病理与123I-FP-CIT SPECT研究

Serotonin Transporter Distribution in the Brainstem of Multiple-System Atrophy-Parkinsonian Type: Insights from Pathology and 123I-FP-CIT SPECT Findings.
PubMed 文献 · J Nucl Med · 2026-04-01

本研究对19例多系统萎缩帕金森型(MSA-P)患者和17例健康对照行123I-FP-CIT SPECT及MRI,计算中脑、脑桥及全脑干的特异性结合比(SBR),并对比部分病例尸检SERT免疫组化。MSA-P组中脑SBR显著降低、脑桥SBR显著升高,全脑干SBR无显著差异;中脑/脑桥比值鉴别MSA-P的AUC为0.93,病理结果与SPECT一致。

要点

  • MSA-P患者中脑SBR显著降低、脑桥SBR显著升高,全脑干SBR无显著差异。
  • 中脑/脑桥SBR比值鉴别MSA-P与健康对照的AUC为0.93。
  • 尸检病理示黑质SERT表达显著降低、脑桥中缝核SERT表达显著增加,与SPECT一致。

核心结论

  • MSA-P患者与健康对照的脑干SERT分布存在差异。

研究设计与样本

  • 研究纳入19例MSA-P患者和17例健康对照,静脉注射123I-FP-CIT后行SPECT和MRI扫描。
  • 生成特异性结合比(SBR)图像,量化中脑、脑桥和全脑干的体素SBR总和。
  • 采用Mann-Whitney U检验比较MSA-P组与健康对照,并用ROC曲线分析中脑/脑桥SBR比值。
  • 对代表性MSA-P病例和健康对照的尸检脑干行SERT免疫组化病理评估。

主要发现

  • MSA-P组中脑体素SBR总和显著降低、脑桥体素SBR总和显著升高(P < 0.05)。
  • MSA-P组与健康对照的全脑干体素SBR总和无显著差异(P < 0.05)。
  • 中脑/脑桥比值用于鉴别的曲线下面积(AUC)为0.93。
  • 病理示MSA-P患者黑质SERT表达显著降低、脑桥中缝核SERT表达显著增加,与SPECT所见一致。

关键数值与推荐

  • 中脑/脑桥体素SBR总和比值鉴别MSA-P与健康对照的AUC为0.93。

临床怎么用

  • 123I-FP-CIT SPECT中脑/脑桥SBR比值或有助于MSA-P与健康对照的鉴别。
  • 判读时应关注脑干区域SERT分布差异,而非仅看全脑干SBR总和。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Studies have demonstrated loss of serotonergic neurons in the brainstems of patients with multiple-system atrophy (MSA). This study aimed to semiquantitatively investigate the status of serotonin transporter (SERT) distribution in the brainstem of individuals with MSA-parkinsonian type (MSA-P) via 123I-2β-carbomethoxy-3β-(4-iodophenyl)nortropane (123I-FP-CIT) SPECT and compare it with pathologic findings in some cases. Methods: We administered 123I-FP-CIT intravenously to 19 patients with MSA-P and 17 healthy controls (HCs) and performed SPECT and MRI scans. Specific binding ratio (SBR) images were generated, and summed voxel-based SBRs for the midbrain, pons, and entire brainstem were quantified. The Mann-Whitney U test was used to compare the MSA-P and HC groups, and receiver operating characteristic curves were used to analyze the midbrain-to-pons ratio of the summed voxel-based SBR. Further, we assessed postmortem SERT immunohistochemistry pathology in the brainstems of representative MSA-P cases and HCs to compare the distribution and density of SERT with SPECT findings. Results: 123I-FP-CIT SPECT results revealed a significant summed voxel-based SBR decrease in the midbrain and an increase in the pons in the MSA-P group, although the brainstem summed voxel-based SBRs did not differ significantly (P < 0.05). The use of the midbrain-to-pons ratio for differentiation generated an area under the curve of 0.93. SERT immunostaining pathology, consistent with the 123I-FP-CIT SPECT findings, demonstrated a significant decrease in SERT expression in the substantia nigra and a significant increase in the pontine raphe nucleus in patients with MSA-P. Conclusion: Our results indicate differences in SERT distribution in the brainstems of patients with MSA-P and HCs.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Shang C, Nagao R, Riku Y, et al. Serotonin Transporter Distribution in the Brainstem of Multiple-System Atrophy-Parkinsonian Type: Insights from Pathology and 123I-FP-CIT SPECT Findings. J Nucl Med. 2026. PMID: 41506799. doi:10.2967/jnumed.124.268669

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。